New collaboration aims to treat cervical cancer

The companies Vaccibody and Roche have started a new collaboration to investigate a drug combination to treat patients with advanced cervical cancer.   Both companies are members of Oslo Cancer Cluster and are involved in the development of novel cancer treatments. Martin Bonde, CEO of Vaccibody, said: “We are very pleased with this collaboration. This is […]

Operation fruit flies

Fruit flies are not only annoying little insects that appear when bananas are overripe. They are also popular research tools for cancer researchers.   The four pupils Kalina Topalova Casadiego, Ida Hustad Andresen, Andreas Bernhus and Dina Düring got to experience how cancer researchers look at fruit flies during their work placement in January.   […]

Getting genomics into healthcare: look to the UK

During Cancer Crosslinks 2019, one thing was crystal clear: there is a need to include broader genomic testing into treatments for cancer patients in Norway. “We are lacking behind here in Norway!” Professor Ola Myklebost, from the Department of Clinical Science at the University of Bergen, was definitely ready for action in the panel debate at Cancer […]

Why a Nordic mentor network is a good idea 

The Nordic Mentor Network of Entrepreneurship (NOME) is the first pan-Nordic mentor network for lifescience start-ups. Why is it a good idea for start-ups working in cancer? Bjørn Klem has an answer. He is the General Manager of Oslo Cancer Cluster Incubator and point of contact for start-ups within the cancer field in Norway. “Start-ups […]

Cancer Crosslinks LIVE streaming

Today, Thursday 17 January, we broadcast LIVE from our conference Cancer Crosslinks at Oslo Cancer Cluster Innovation Park. Please join us and hear from a distinguished panel of international and Norwegian experts as they discuss the Next Wave of Precision Oncology, share new perspectives, and address the challenges and opportunities ahead. The subtitle of this […]